Navigation Links
Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
Date:10/31/2008

SHANGHAI, China, Oct. 31 /Xinhua-PRNewswire/ -- Sundia MediTech Company, a Shanghai-based drug discovery and pharmaceutical development outsourcing service company (CRO) received this year's Deloitte Technology Fast 50 China award, and ranked number 16. The result of Deloitte Technology Fast 50 China Program was announced today in Shenzhen, China at a special ceremony.

Deloitte Technology Fast 50 Program started in 1995 in San Jose. This program quickly expanded to numerous cities and countries. In 2005, Deloitte China launched the "Deloitte Technology Fast 50 China" program. Participants in the Deloitte Technology Fast 50 China program will automatically qualify for participation in the Deloitte Technology Fast 500 Asia Pacific 2008 program, which annually recognises the 500 fastest growing technology companies in Asia Pacific.

Sundia was named consecutively in 2007 and 2008 as one of the top 50 most valuable companies for investment in China. About the Deloitte Technology Fast award, Dr. Xiaochuan Wang, Sundia's CEO said "it is another recognition of Sundia's achievement, and also recognition of China's CRO industry development."

Sudia has kept a high speed for business growth in the 4 and half year history of the company. Last year, Sundia successfully merged with another CRO company United Pharmatech Company in Shanghai. According to Dr. Shi Xiongwei, the founder of United Pharmatech and now Executive VP of Sundia, the company has expanded its business scope from the original chemistry service area to cover most drug discovery and pharmaceutical development areas. The company has made significant contribution to some new drug development programs for clients. Through closely working with client companies, they have successfully advanced a few programs to preclinical or clinical stage.

Sundia's CFO Mr. Beijia Yu and Vice President Dr. Jiong Chen attended today's ceremony to receive "Deloitte Technology Fast 50 China" award.

About the Company

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 4 years, Sundia has built a strong reputation in its field.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
2. Abt Associates Ranked One of Top 20 U.S. Market Research Firms
3. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
4. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
5. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
6. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
7. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
8. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
11. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... VILLAGE, Calif. , March 24, 2017   ... dermatology and aesthetics company, today announced that Richard ... Officer, effective March 24.   Peterson, who brings ... succeed John Smither , who is retiring at ... Sienna in an advisory capacity. Peterson joins Sienna from ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? ... partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 years ...
Breaking Biology Technology:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... , March 21, 2017 Vigilant ... company serving law enforcement agencies, announced today the appointment ... as director of public safety business development. ... law enforcement experience, including a focus on the aviation ... his most recent position, Mr. Sheridan served as the ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):